Preoperative hormonal assessments showed that prolactin (PRL) and follicle-stimulating hormone (FSH) were above the upper limit of their reference intervals; however, no overt related clinical symptoms existed, and the tumor behaved as a “clinically non-functioning” adenoma [10]. Here, BRD2 is linked to neoplasm.